Toyama, Japan

Yukihiko Aikawa

USPTO Granted Patents = 8 


Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 1999-2015

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovator in Pharmaceuticals: The Contributions of Yukihiko Aikawa

Introduction: Yukihiko Aikawa is a distinguished inventor based in Toyama, Japan, recognized for his substantial contributions to the field of pharmaceuticals. With a robust portfolio of 8 patents, Aikawa has made significant strides in developing innovative treatments for autoimmune diseases and osteoporosis.

Latest Patents: Among his latest patented inventions is a novel method that utilizes a combination of a benzophenone derivative or its salt and an immunosuppressing agent. This inventive method, along with a pharmaceutical composition comprising these components, showcases the application of a benzophenone derivative (represented by a specific general formula) in treating or preventing autoimmune diseases. The composition is characterized by its various substituents, which enhance its therapeutic efficacy. Another noteworthy patent focuses on a drug that contains benzophenone derivatives, demonstrating their suppressive effects on RANKL production and inhibition of osteoclast differentiation. This research is pivotal for advancing treatments for conditions such as osteoporosis.

Career Highlights: Yukihiko Aikawa is primarily affiliated with Toyama Chemical Co., Ltd., where he has been instrumental in pushing the boundaries of pharmaceutical research. His innovative approaches and dedication to solving complex medical issues have earned him respect in the industry, along with numerous patents that testify to his ingenuity.

Collaborations: Throughout his career, Aikawa has collaborated with esteemed colleagues, including Shunichi Shiozawa and Keiichi Tanaka. These partnerships have played a crucial role in the successful development of various pharmaceutical formulations and therapeutic methods, contributing to advancements in treatments for serious health conditions.

Conclusion: Yukihiko Aikawa stands out as a prominent inventor in the pharmaceutical arena. His dedication to innovation and collaboration reflects a commitment to improving healthcare outcomes. With his significant number of patents and ongoing contributions, Aikawa continues to pave the way for future advancements in the treatment of autoimmune diseases and other related disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…